retatrutide type 2 diabetes trial results 2024 produces up to 30.3% weight loss in Phase 3 Weight loss with retatrutide as

Ready to learn more about Sofwave

Cuntos viales necesito Para las primeras 20 semanas (fase de escalada): Semaglutida (referencia STEP 1 STEP-1

New therapeutic opportunities shared by obesity, type 2 diabetes and rheumatoid arthritis

Arrhythmic risk stratification by cardiovascular magnetic resonance imaging in patients with nonischemic cardiomyopathy

Q3: What causes ozempic face aging from a medical aesthetic standpoint

Building on the promising approach of dual-targeting immune checkpoints and the TGF- pathway, scientists have engineered innovative CAR-T cells that produce bifunctional trap proteins directed against both PD-1 and TGF-